Peri‐Implant Bone Regeneration Using Rhpdgf‐bb, BMSCs, and Β‐tcp in a Canine Model

Ling Xu,Wenjie Zhang,Kaige Lv,Weiqiang Yu,Xinquan Jiang,Fuqiang Zhang
DOI: https://doi.org/10.1111/cid.12259
2015-01-01
Clinical Implant Dentistry and Related Research
Abstract:BackgroundThe presence of insufficient bone volume remains a major clinical problem for dental implant placement to restore oral function. Tissue engineering provides a promising approach for inducing bone regeneration and enhancing osseointegration in dental implants.PurposeThe tissue-engineered bone consisting of recombinant human platelet-derived growth factor (rhPDGF-BB), bone marrow stem cells (BMSCs), and beta-tricalcium phosphate (-TCP) particles was validated for the first time in a preclinical large animal canine model in terms of its ability to promote new bone formation around the implants, as well as osseointegration between the tissue-engineered bone and dental implants.Materials and MethodsProliferation and osteogenic differentiation of canine BMSCs treated with rhPDGF-BB were evaluated with an MTT, alkaline phosphatase (ALP) activity, Alizarin Red staining, and real-time quantitative PCR (RT-qPCR) analysis of osteogenic genes. The therapeutic potential of tissue-engineered bone consisting of rhPDGF-BB/BMSCs/-TCP in bone repair was evaluated in mesial-implant defects of immediate postextraction implants in the canine mandible.ResultsrhPDGF-BB treatment significantly increased proliferation and osteogenic differentiation of canine BMSCs. Furthermore, the tissue-engineered bone consisting of rhPDGF-BB/BMSCs/-TCP significantly enhanced bone formation and osseointegration.ConclusionThis study provides important evidence that supports the potential application of rhPDGF-BB/BMSCs/-TCP tissue-engineered bone in immediate implantation for oral function restoration.
What problem does this paper attempt to address?